Regorafenib

Name: Regorafenib
Availability: regorafenib-357355.html

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:Regorafenib
CAS No.:755037-03-7
Standard:In-house Standards
Price(USD):Negotiable
Company:Shenzhen Haorui Pharmatech Co., Ltd.

Send Inquiry

Favorites

Similar Products

4-Amino-3-Phenibut Acid HCl (Phenibut)

Sodium Hyaluronate Topical Grade

6-Chloro-4-Methoxynicotinic acid

Lubiprostone

1,1-Dimethylthio-2-Nitroethene(BMNE)

Metamizole Sodium(Analgin)

2-Pyrrolidinone

1-methyl-4-nitro-1H-pyrazole-3-carboxylic acid

Valaciclovir Hydrochloride

N-([1,1'-biphenyl]-4-yl)-6-(naphthalen-1-yl)-[1,1'-biphenyl]-3-amine

Basic Info

Grade: Pharmaceutical Grade

Factory Location: Hubei

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no

Payment Terms: L/C

Regorafenib is an orally-administered inhibitor of multiple kinases. It is used for the treatment of metastatic colorectal cancer, advanced gastrointestinal stromal tumours, and hepatocellular carcinoma. FDA approved on September 27, 2012. Approved use of Regorafenib was expanded to treat Hepatocellular Carcinoma in April 2017.

Send your message to this supplier

From:
To:
Shenzhen Haorui Pharmatech Co., Ltd.
Send a Copy to this Email
Message:
Upload Images / Files
- Supports jpg, jpeg, png,
gif, pdf, doc, docx,
xls, xlsx, txt, rar and zip
- Max upload 3 files;
Max total size: 3MB
(0/3)

Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now
Verification:

Other Products from this supplier
More>>

Granisetron Hydrochloride

Dasatinib monohydrate

Flumazenil

Docetaxel anhydrous

Epinastine Hydrochloride

Desvenlafaxine succinate

Neostigmine Methylsulfate

Venlafaxine hydrochloride

Vancomycin Hydrochloride

Daptomycin

Regorafenib

Other Products from this supplierMore>>

Other Products from this supplier
More>>